Randomised controlled trialindependent cross-checkabstract checked I-LEG-126 standard review

Lentil meals for 8 weeks

Eight weeks of lentil consumption attenuates insulin resistance progression without increased gastrointestinal symptom severity: A randomized clinical trial.

Overview

Wilson SMG et al.. Nutr Res 2022 · PMID 36122501 · DOI 10.1016/j.nutres.2022.08.002

Lentil meals improved insulin resistance, and most participants had no or only mild gut symptoms.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Test lentils on glucose and GI symptoms.

How was the study done?

RCT.

How many people, animals or samples were studied?

30 adults.

What was actually found?

Better HOMA-IR; mild symptoms.

How large was the observed effect?

HOMA-IR -1.5 (high dose).

What do the results mean in everyday life?

Lentils are well tolerated by most people.

What are the study's limitations?

Small; short.

What does it say about Elawady's specific claim?

Contradicts C-LEG-09/13.

Do the results apply to Germany and Europe?

Applicable.

What can explicitly not be concluded from this study?

It does not show long-term outcomes.

Scientific in-depth review

1. Full reference

Authors
Wilson SMG et al.
Journal
Nutr Res
Year
2022
Identifier
PMID 36122501 DOI 10.1016/j.nutres.2022.08.002
Verification
verified – PubMed efetch 2026-10-26 + Crossref works API
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

No conflict of interest declared.

2. Research question

Do lentil-based meals improve glycaemic control and how severe are GI symptoms?

3. Study design and population

Study design
Randomised controlled trial – Randomised controlled dietary intervention (8 weeks, three lentil doses)
Population

Nondiabetic adults with increased waist circumference

Country

Not stated in abstract

Period

8 weeks

Sample size

30 completers

Inclusion and exclusion criteria

Waist >40 in (men), >35 in (women); nondiabetic.

4. Methods and endpoints

Exposure / intervention

300 g or 600 g cooked green lentils per week in midday meals

Comparator

Meat-based meals (0 g lentils)

Endpoints

HOMA-IR, glucose/insulin AUC, satiety, GI symptoms

Statistical methods

Linear models

5. Actual results

Results

HOMA-IR +1.2 in control vs -0.9 (P=.03) and -1.5 (P<.01) with moderate and high lentil doses; 87.4% reported no to mild GI symptoms; bloating, abdominal discomfort and cramping severity 0.3-0.5 units lower.

Absolute risks

Not applicable

Authors' conclusion

Dose-dependent reduction of rising insulin resistance with low GI symptom severity.

6. Strengths

  • Randomised dose groups
  • Prepared meals

7. Weaknesses

  • Small
  • Short
  • Abstract only

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Small sample, unblinded.

9. Assessment of the statistical interpretation

Effect plausible but imprecise.

10. Relevance to the specific claim

Regular lentil meals caused mostly no or mild GI symptoms and improved insulin resistance (contradicts C-LEG-09 and C-LEG-13).

11. Independent contrary findings

None.

12. Transferability to Germany and Europe

Applicable.

13. Overall methodological judgement

Supports tolerance and benefit of lentils.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Longer trials.

15. Linked fact checks